Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 8/20 | 0.34 |
| ▸ | CES1 | P23141 | 5/20 | 0.33 |
| ▸ | CES2 | O00748 | 3/20 | 0.33 |
| ▸ | OXER1 | Q8TDS5 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.32 |
| ▸ | CYSLTR2 | Q9NS75 | 1/20 | 0.30 |
| ▸ | CYSLTR1 | Q9Y271 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL866440 | 0.92 | FAAH (0.31) | FAAHCES1CES2OXER1MEN1 | |
| SCHEMBL1648852 | 0.81 | FAAH (0.36) | FAAHCES1CES2OXER1MEN1 | |
| SCHEMBL865199 | 0.80 | — | — | |
| SCHEMBL1766736 | 0.79 | FAAH (0.35) | FAAHCES1CES2OXER1MEN1 | |
| SCHEMBL8744170 | 0.79 | FAAH (0.34) | FAAHCES1CES2OXER1MEN1 | |
| SCHEMBL866445 | 0.79 | LMNA (0.58) | OXER1MEN1KMT2AHSD17B10ALOX5 | |
| SCHEMBL23303403 | 0.77 | ALDH1A1 (0.46) | FAAHCES1CES2OXER1MEN1 | |
| SCHEMBL20543468 | 0.77 | FAAH (0.37) | FAAHCES1CES2OXER1MEN1 | |
| SCHEMBL1766732 | 0.77 | FAAH (0.33) | FAAHCES1CES2OXER1MEN1 | |
| SCHEMBL21850118 | 0.77 | TSHR (0.60) | MEN1KMT2AHSD17B10LMNAALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023174773-A1 | PHOTOALIGNING MATERIALS | Rolic Technologies AG (CH) | 2023-09-21 | — | — | WO | disclosed |
| EP-3081552-B1 | PEST CONTROL AGENT CONTAINING AN AMIDE DERIVATIVE AND USE OF THE PEST CONTROL AGENT | MITSUI CHEMICALS AGRO INC (JP) | 2021-03-03 | — | — | EP | disclosed |
| US-10582708-B2 | Amide derivative, pest control agent containing the amide derivative, and use of the amide derivative | MITSUI CHEMICALS AGRO, INC. (JP) | 2020-03-10 | — | — | US | disclosed |
| EP-2325165-B1 | AMIDE DERIVATIVE, PEST CONTROL AGENT CONTAINING THE AMIDE DERIVATIVE AND PEST CONTROLLING METHOD | MITSUI CHEMICALS AGRO INC (JP) | 2020-02-19 | — | — | EP | disclosed |
| US-10208031-B2 | Photocrosslinkable materials comprising alicyclic group | ROLIC AG (CH) | 2019-02-19 | — | — | US | disclosed |
| US-20170367329-A1 | AMIDE DERIVATIVE, PEST CONTROL AGENT CONTAINING THE AMIDE DERIVATIVE, AND USE OF THE AMIDE DERIVATIVE | MITSUI CHEMICALS CROP & LIFE SOLUTIONS, INC. (JP) | 2017-12-28 | — | — | US | disclosed |
| US-20170362381-A1 | THERMALLY STABLE ALIGNMENT MATERIALS | ROLIC AG (CH) | 2017-12-21 | — | — | US | disclosed |
| US-9756856-B2 | Amide derivative, pest control agent containing the amide derivative, and use of the amide derivative | MITSUI CHEMICALS AGRO, INC. (JP) | 2017-09-12 | — | — | US | disclosed |
| EP-3205642-A2 | AMIDE DERIVATIVE, PEST CONTROL AGENT CONTAINING THE AMIDE DERIVATIVE AND PEST CONTROLLING METHOD | Mitsui Chemicals Agro, Inc. (JP) | 2017-08-16 | — | — | EP | disclosed |
| EP-2319830-B1 | AMIDE DERIVATIVE, PEST CONTROL AGENT CONTAINING THE AMIDE DERIVATIVE, AND USE OF THE PEST CONTROL AGENT | MITSUI CHEMICALS AGRO INC (JP) | 2016-11-02 | — | — | EP | disclosed |
| EP-2144951-A1 | THERMALLY STABLE ALIGNMENT MATERIALS | Rolic AG (CH) | 2010-01-20 | — | — | EP | disclosed |
| EP-2142957-A1 | METHOD OF UNIFORM AND DEFECT FREE LIQUID CRYSTAL ALIGNING LAYERS | Rolic AG (CH) | 2010-01-13 | — | — | EP | disclosed |
| WO-2008145225-A2 | PHOTOCROSSLINKABLE MATERIALS COMPRISING ALICYCLIC GROUP | ROLIC AG (CH) | 2008-12-04 | — | — | WO | disclosed |
| US-20080293888-A1 | Photocrosslinkable Materials | ROLIC AG (CH) | 2008-11-27 | — | — | US | disclosed |
| WO-2008135131-A1 | THERMALLY STABLE ALIGNMENT MATERIALS | ROLIC AG (CH) | 2008-11-13 | — | — | WO | disclosed |
| WO-2008119449-A1 | METHOD OF UNIFORM AND DEFECT FREE LIQUID CRYSTAL ALIGNING LAYERS | ROLIC AG (CH) | 2008-10-09 | — | — | WO | disclosed |
| EP-1975687-A1 | Method of uniform and defect free liquid crystal aligning layers | Rolic AG (CH) | 2008-10-01 | — | — | EP | disclosed |
| EP-1966119-A1 | PHOTOCROSSLINKABLE MATERIALS | Rolic AG (CH) | 2008-09-10 | — | — | EP | disclosed |
| EP-1860094-A1 | Photocrosslinkable materials | Rolic AG (CH) | 2007-11-28 | — | — | EP | disclosed |
| WO-2007071091-A1 | PHOTOCROSSLINKABLE MATERIALS | ROLIC AG (CH) | 2007-06-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10208031-B2 | Photocrosslinkable materials comprising alicyclic group | DDC, ALAD, DYNC1LI1 | FAAH 434/4885CES1 3935/4885CES2 3343/4885 |
| US-20080293888-A1 | Photocrosslinkable Materials | DDC, PARG, ALAD | FAAH 693/4885CES1 4376/4885CES2 3094/4885 |
| US-10582708-B2 | Amide derivative, pest control agent containing the amide derivative, and use of the amide derivative | H1-2, H1-4, H1-0 | FAAH 168/4885CES1 914/4885CES2 936/4885 |
| US-20170367329-A1 | AMIDE DERIVATIVE, PEST CONTROL AGENT CONTAINING THE AMIDE DERIVATIVE, AND USE OF THE AMIDE DERIVATIVE | H1-2, H1-4, H1-0 | FAAH 168/4885CES1 914/4885CES2 936/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.